RCRoberta Cortivo

Roberta Cortivo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roberta Cortivo has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 July 2010
      • Vol. 10  (50) , 37-43

    Neural potential of adipose stem cells.

    by Barbara Zavan, Vincenzo Vindigni, Chiara Gardin, Domenico D'Avella, Alessandro Della Puppa, Giovanni Abatangelo, Roberta Cortivo

    In the last few years, adipose tissue, which has been largely ignored by anatomists and physicians for centuries, has found new brightness thanks to the stem cells contained within. These adipose derived stem cells (ADSC) have the same characteristics of the mesenchymal stem cells (MSC) residing in bone marrow. They have the same cell surface markers and are capable of differentiating into the same cell types, including osteoblasts, chondrocytes, myoblasts, adipocytes, and neuron-like cells. Adipose tissue is ubiquitous and uniquely expandable. Most patients possess excess fat that can be harvested, making adipose tissue the ideal large-scale source for research on clinical applications. In this review focused on the neural potential of adipose-derived stem cells. Current strategies for their isolation, differentiation, and in vitro characterization, as well as their latest in vivo applications for neurological disorders or injury repair, were discussed.


  • Open Access

    Hyaluronan Benzyl Ester as a Scaffold for Tissue Engineering

    by Vincenzo Vindigni, Roberta Cortivo, Laura Iacobellis, Giovanni Abatangelo, Barbara Zavan

    Tissue engineering is a multidisciplinary field focused on in vitro reconstruction of mammalian tissues. In order to allow a similar three-dimensional organization of in vitro cultured cells, biocompatible scaffolds are needed. This need has provided immense momentum for research on “smart scaffolds” for use in cell culture. One of the most promising materials for tissue engineering and regenerative medicine is a hyaluronan derivative: a benzyl ester of hyaluronan (HYAFF®). HYAFF® can be processed to obtain several types of devices such as tubes, membranes, non-woven fabrics, gauzes, and sponges. All these scaffolds are highly biocompatible. In the human body they do not elicit any adverse reactions and are resorbed by the host tissues. Human hepatocytes, dermal fibroblasts and keratinocytes, chondrocytes, Schwann cells, bone marrow derived mesenchymal stem cells and adipose tissue derived mesenchymal stem cells have been successfully cultured in these meshes. The same scaffolds, in tube meshes, has been applied for vascular tissue engineering that has emerged as a promising technology for the design of an ideal, responsive, living conduit with properties similar to that of native tissue.


  • Hydrogels and Tissue Engineering

    by Barbara Zavan, Roberta Cortivo, Giovanni Abatangelo


  • Open Access

    Characteristics of repair tissue in second-look and third-look biopsies from patients treated with engineered cartilage: relationship to symptomatology and time after implantation

    by Paola Brun, Sally C Dickinson, Barbara Zavan, Roberta Cortivo, Anthony P Hollander, Giovanni Abatangelo

    Introduction: The present study established characteristics of tissue regrowth in patients suffering knee lesions treated with grafts of autologous chondrocytes grown on three-dimensional hyaluronic acid biomaterials. Methods: This multicentred study involved a second-look arthroscopy/biopsy, 5 to 33 months post implant (n = 63). Seven patients allowed a third-look biopsy, three of which were performed 18 months post implant. Characteristics of tissues were histologically and histochemically evaluated. The remaining bone stubs were evaluated for cartilage/bone integration. For data analysis, biopsies were further divided into those obtained from postoperative symptomatic patients (n = 41) or from asymptomatic patients (n = 22). Results: The percentage of hyaline regenerated tissues was significantly greater in biopsies obtained after, versus within, 18 months of implantation. Differences were also observed between symptomatic and asymptomatic patients: reparative tissues taken from symptomatic patients 18 months after grafting were mainly fibrocartilage or mixed (hyaline–fibrocartilage) tissue, while tissues taken from asymptomatic patients were hyaline cartilage in 83% of biopsies. In a small group of asymptomatic patients (n = 3), second-look and third-look biopsies taken 18 months after surgery confirmed maturation of the newly formed tissue over time. Cartilage maturation occurred from the inner regions of the graft, in contact with subchondral bone, towards the periphery of the implant. Conclusions: The study indicates that, in asymptomatic patients after chondrocyte implantation, regenerated tissue undergoes a process of maturation that in the majority of cases takes longer than 18 months for completion and leads to hyaline tissue and not fibrous cartilage. Persistence of symptoms might reflect the presence of a nonhyaline cartilage repair tissue.


  • Use of Hyaluronic Acid-Based Temporary Scaffold as an In Vivo “Bioreactor” for Complete Microvascular Regeneration

    by Vincenzo Vindigni, Sandro Lepidi, Roberta Cortivo, Barbara Zavan, Giovanni Abatangelo

    The aim of this presented study was to evaluate a prosthetic graft capable of performing adequately as a small diameter conduit (2 mm diameter), using an in vivo tissue engineering approach. The authors decided to reproduce and positively guide the remodelling process directly in vivo, using a 2 mm in diameter and 1 cm in length hyaluronic acid-based tubular scaffold (HYAFF-11) that functioned only as a temporary absorbable guide, similar to an in vivo “artery bioregeneration assist tube” (ABAT). This biomaterial was chosen for its documented capacity to promote adhesion and proliferation of endothelial and smooth muscle vascular cells. Its biodegradability and biocompatibility were also well-documented. Thirty male Wistar rats weighing 250 to 350 g were used. The aorta, from the renal arteries to the aortic trifurcation, was exposed and isolated. A segment of aorta (1 cm) was incised and a HYAFF 11™ tube was anastomosed, first proximally and then distally, in an end-to-end fashion with interrupted stitches of 10-0 nylon suture. No anticoagulants were used either before or after the operation. Histologic (hematoxylin-eosin and Weighert solution), immunohistochemical (antibodies to von Willebrand factor, CD34, vascular endothelial growth factor receptor-2 and to myosin light chain kinase) and ultra-structural analysis were used to evaluate the results at 5, 15, 30, 60, 120, and 180 days after surgery. Three novel findings stood out in evaluation of results: endothelialization of the tube luminal surface within 5 days; sequential regeneration of the other vascular components that led to complete vascular-wall regeneration after 15 days post surgery; and temporariness of the tube – biomaterial was entirely degraded after 4 months post implantation and, after that, a new artery remained to connect artery stumps. This study assessed the feasibility of creating a completely biodegradable vascular regeneration guide in vivo. The most important finding was the ability of the proposed vascular prostheses to sequentially orchestrate the vascular regeneration events required for very small artery reconstruction. Until now, this has been defined as the holy grail of vascular biology, given the great difficulty in obtaining in vivo significant long-term patency and acceptable wall mechanical strength.

  • In vitro engineering of human skin‐like tissue

    by Valentina Zacchi, Carlo Soranzo, Roberta Cortivo, Marco Radice, Paola Brun, Giovanni Abatangelo